Increased Cardiovascular Risk in Young Patients with CKD and the Role of Lipid-Lowering Therapy

被引：0
|
作者：
Vojtech Kratky
Anna Valerianova
Zdenka Hruskova
Vladimir Tesar
Jan Malik
机构：
[1] Charles University and General University Hospital in Prague,Department of Nephrology, First Faculty of Medicine
[2] Charles University and General University Hospital in Prague,3rd Department of Internal Medicine, First Faculty of Medicine
来源：
Current Atherosclerosis Reports | 2024年 / 26卷
关键词：
Cardiovascular Disease; Vascular Pathology; Chronic Kidney Disease; Dyslipidemia; Lipid-lowering Drugs;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：103 / 109
页数：6
相关论文
共 50 条
  • [21] Increased CK levels in lipid-lowering therapy
    Assmann, G
    INTERNIST, 1997, 38 (11): : 1114 - 1114
  • [22] Cardiovascular risk factors and use of lipid-lowering therapy in a cohort of HIV-positive patients with high cardiovascular risk
    Denman, Johanna
    Manavi, Kaveh
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
  • [23] The Role of Nutraceuticals in the Optimization of Lipid-Lowering Therapy in High-Risk Patients with Dyslipidaemia
    Penson, Peter E.
    Banach, Maciej
    CURRENT ATHEROSCLEROSIS REPORTS, 2020, 22 (11)
  • [24] METABOLIC EFFECTS OF DIFFERENT LIPID-LOWERING THERAPY REGIMENS IN HYPERTENSIVE PATIENTS WITH HIGH CARDIOVASCULAR RISK
    Koshelskaya, O.
    Sushkova, A.
    Kravtshenko, E.
    Suslova, T.
    JOURNAL OF HYPERTENSION, 2017, 35 : E193 - E194
  • [25] The Role of Nutraceuticals in the Optimization of Lipid-Lowering Therapy in High-Risk Patients with Dyslipidaemia
    Peter E. Penson
    Maciej Banach
    Current Atherosclerosis Reports, 2020, 22
  • [26] Lipid-lowering therapy for patients with or at risk of coronary artery disease
    Kjekshus, J
    Pedersen, TR
    Tobert, JA
    CURRENT OPINION IN CARDIOLOGY, 1996, 11 (04) : 418 - 427
  • [27] Changes in lipid-lowering therapy following a cardiovascular event in patients with diabetes
    Okerson, T.
    Cohen, S. S.
    Killian, J. M.
    Weston, S. A.
    Monda, K. L.
    Chamberlain, A. M.
    DIABETOLOGIA, 2017, 60 : S537 - S538
  • [28] Lipid-lowering therapy - New and established agents reduce risk of cardiovascular events
    Smith, CR
    POSTGRADUATE MEDICINE, 2004, 115 (03) : 29 - +
  • [29] Lipid-lowering therapy today: Treating the high-risk cardiovascular patient
    Berra, Kathleen
    JOURNAL OF CARDIOVASCULAR NURSING, 2008, 23 (05) : 414 - 421
  • [30] Lipid-Lowering Treatment and the Lipid Goals Attainment in Patients with a Very High Cardiovascular Risk
    Lis, Anna
    Lis, Paulina
    Lowicka, Weronika
    Grabarczyk, Malgorzata
    Wita, Michal
    Zarczynski, Piotr
    Zarczynska, Malgorzata
    Haberka, Maciej
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2023, 10 (08)
12345